Synaptogenix (SNPX) Stock Chart & Stock Price History $2.96 -0.02 (-0.67%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Synaptogenix Stock Price Performance5 Day Performance-8.07%1 Month Performance-1.33%3 Month Performance-21.49%6 Month Performance-37.82%Year-To-Date Performance-56.45%1 Year Performance-58.95% Receive SNPX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Synaptogenix and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Click here to watch it now. SNPX Stock Chart for Saturday, November, 2, 2024 SNPX Chart by TradingView Synaptogenix Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024$2.98$2.96-0.67%$3.04$2.963,977 shs$4.03 million10/31/2024$3.08$2.98-3.09%$3.10$2.988,417 shs$4.04 million10/30/2024$3.18$3.08-3.30%$3.17$3.0128,200 shs$4.17 million10/29/2024$3.22$3.18-1.24%$3.22$3.1012,115 shs$4.33 million10/28/2024$3.08$3.22+4.51%$3.22$3.0918,353 shs$4.38 million10/25/2024$3.14$3.10-1.27%$3.17$3.0715,510 shs$4.22 million Get the Latest News and Ratings for SNPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Synaptogenix and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024$3.20$3.14-1.72%$3.24$3.1119,303 shs$4.27 million10/23/2024$3.48$3.20-8.19%$3.37$3.136,421 shs$3.94 million10/22/2024$3.60$3.48-3.33%$3.53$3.3023,745 shs$4.29 million10/21/2024$3.24$3.60+11.17%$3.70$3.2178,518 shs$4.90 million10/18/2024$3.11$3.23+3.86%$3.29$3.1152,539 shs$4.39 million10/17/2024$3.31$3.11-6.04%$3.27$3.0450,597 shs$4.23 million10/16/2024$3.00$3.31+10.33%$3.42$3.03137,868 shs$4.08 million10/15/2024$2.82$3.00+6.38%$3.40$2.84138,090 shs$3.70 million10/14/2024$2.96$2.82-4.73%$2.94$2.826,433 shs$3.48 million10/11/2024$2.96$2.96$2.96$2.871,486 shs$3.65 million10/10/2024$2.98$2.96-0.67%$2.96$2.8111,672 shs$3.88 million10/09/2024$2.97$2.98+0.34%$3.15$2.9621,279 shs$3.90 million10/08/2024$2.86$2.97+3.85%$3.20$2.8618,876 shs$3.66 million10/07/2024$2.90$2.86-1.38%$3.00$2.7632,861 shs$3.53 million10/04/2024$2.91$2.90-0.34%$3.20$2.8915,905 shs$3.58 million10/03/2024$3.00$2.91-3.00%$3.02$2.8810,414 shs$3.81 million10/02/2024$3.04$3.00-1.32%$3.14$2.9715,248 shs$3.93 million10/01/2024$3.02$3.04+0.66%$3.13$2.9817,935 shs$3.98 million09/30/2024$2.97$3.02+1.65%$3.12$2.9712,742 shs$3.72 million09/27/2024$3.14$2.97-5.41%$3.37$2.978,758 shs$3.89 million09/26/2024$3.10$3.14+1.29%$3.25$2.9822,557 shs$3.87 million09/25/2024$3.09$3.10+0.32%$3.19$3.048,825 shs$3.82 million09/24/2024$3.11$3.09-0.64%$3.24$3.0110,199 shs$3.81 million09/23/2024$3.34$3.11-6.89%$3.29$3.1011,436 shs$3.84 million09/20/2024$3.26$3.34+2.45%$3.34$3.229,009 shs$4.12 million09/19/2024$3.24$3.26+0.62%$3.34$3.266,246 shs$4.27 million09/18/2024$3.21$3.24+0.93%$3.44$3.2434,736 shs$4.00 million09/17/2024$3.07$3.21+4.56%$3.21$3.0216,875 shs$3.96 million09/16/2024$3.16$3.07-2.85%$3.18$3.0116,718 shs$3.79 million09/13/2024$2.85$3.16+10.88%$3.16$2.8928,763 shs$4.14 million09/12/2024$2.86$2.85-0.35%$2.99$2.7236,884 shs$3.73 million09/11/2024$3.54$2.86-19.21%$3.60$2.80137,090 shs$3.75 million09/10/2024$3.45$3.54+2.61%$3.67$3.4813,524 shs$4.64 million09/09/2024$3.45$3.45$3.59$3.409,285 shs$4.52 millionSell NVDA Now? (Ad)Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA).09/06/2024$3.56$3.45-3.09%$3.64$3.3554,572 shs$4.39 million09/05/2024$3.59$3.56-0.84%$3.73$3.4423,134 shs$4.66 million09/04/2024$3.69$3.59-2.71%$3.74$3.3842,245 shs$4.70 million09/03/2024$3.96$3.69-6.82%$3.96$3.5651,141 shs$4.83 million09/02/2024$3.96$3.96+0.10%$4.09$3.70272,600 shs$4.88 million08/30/2024$3.53$3.96+12.18%$4.09$3.70269,597 shs$5.19 million08/29/2024$3.58$3.53-1.26%$3.62$3.5012,955 shs$4.35 million08/28/2024$3.77$3.58-5.17%$3.71$3.554,807 shs$4.41 million08/27/2024$3.72$3.77+1.34%$3.80$3.593,616 shs$4.65 million08/26/2024$3.63$3.72+2.48%$3.90$3.5913,278 shs$4.59 million08/23/2024$3.73$3.63-2.68%$3.94$3.6126,445 shs$4.48 million08/22/2024$3.80$3.73-1.84%$4.00$3.6738,746 shs$4.89 million08/21/2024$3.75$3.80+1.33%$3.91$3.726,241 shs$4.98 million08/20/2024$3.57$3.75+5.04%$3.75$3.573,289 shs$4.62 million08/19/2024$3.70$3.57-3.51%$3.79$3.577,438 shs$4.40 million08/16/2024$3.61$3.70+2.49%$3.81$3.666,582 shs$4.56 million08/15/2024$3.73$3.61-3.22%$3.77$3.5525,334 shs$4.45 million08/14/2024$3.79$3.73-1.58%$3.73$3.555,607 shs$4.60 million08/13/2024$3.57$3.79+6.16%$3.88$3.5219,924 shs$4.66 million08/12/2024$3.57$3.57$3.66$3.4120,587 shs$4.40 million08/09/2024$3.55$3.57+0.56%$3.64$3.4812,185 shs$4.39 million08/08/2024$3.43$3.55+3.50%$3.59$3.465,484 shs$4.37 million08/07/2024$3.51$3.43-2.28%$3.48$3.429,812 shs$4.22 million08/06/2024$3.59$3.51-2.23%$3.77$3.5018,638 shs$4.32 million08/05/2024$3.77$3.59-4.77%$3.67$3.2749,309 shs$4.42 million08/02/2024$4.04$3.77-6.68%$4.00$3.5642,902 shs$4.64 million08/01/2024$4.05$4.04-0.25%$4.07$3.938,905 shs$4.97 million Related Companies Sol-Gel Technologies Stock Price Chart Synlogic Stock Price Chart GeoVax Labs Stock Price Chart HCW Biologics Stock Price Chart ImmunoPrecise Antibodies Stock Price Chart Talphera Stock Price Chart Marinus Pharmaceuticals Stock Price Chart Chemomab Therapeutics Stock Price Chart AIM ImmunoTech Stock Price Chart NLS Pharmaceutics Stock Price Chart Receive SNPX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Synaptogenix and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SNPX) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synaptogenix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Synaptogenix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.